Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
M Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.
BJU International
|
June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance
John W Davis, John F Ward, Curtis A Pettaway, et al.
BJU International
|
September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort
Pierre Blanchard, John W Davis, Steven J Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2018
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
Sarah L Kerns, Chunkit Fung, Patrick O Monahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
Heather E Wheeler, Eric R Gamazon, Robert D Frisina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
Science Signaling
|
May 25, 2017
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li, Styliani Karanika, Guang Yang, et al.
Ebiomedicine
|
June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer
Jeri Kim, John W Davis, Eric A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward
Gary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
M Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.
BJU International
|
June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance
John W Davis, John F Ward, Curtis A Pettaway, et al.
BJU International
|
September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort
Pierre Blanchard, John W Davis, Steven J Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2018
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
Sarah L Kerns, Chunkit Fung, Patrick O Monahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
Heather E Wheeler, Eric R Gamazon, Robert D Frisina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
Science Signaling
|
May 25, 2017
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li, Styliani Karanika, Guang Yang, et al.
Ebiomedicine
|
June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer
Jeri Kim, John W Davis, Eric A Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward
Gary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Page
of 11